United Kingdom (UK) HQ Kings Cross 344 – 354, Grays Inn Road, London, WC1X 8BP
India (IN)Fiesta Building, 2nd Floor, Survey No. 35/2/1/2, Mumbai – Bangalore Bypass, Baner, Pune, Maharashtra – 411045
HR: email@example.com General enquiries: firstname.lastname@example.org Sales: email@example.com
For any app related concerns, you can raise a support ticket*.
*Please note that we do not provide any medical advice through the website/app. Any information on this website/app is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. We are only responsible for facilitating the interaction between you and the medical professionals through the website/app. We are not responsible or liable for any advice, course or treatment, diagnosis or any other information, that you may obtain through this website/app. All medical advice, diagnosis and treatment on the website/app are provided through registered medical professionals. Many of the physicians affiliated with our service are independent practitioners and are neither our employees nor our agents and we are not responsible for the care provided by them.
Get in touch to see how you can use HealthMachine™ to deliver a transformative digital health product to your patients in under 3 months.
Problem Pulmonary arterial hypertension (PAH) is a rare, progressive, and life-threatening condition, for which there is no cure and therefore requires constant management by patients. Avegen was given the task to set-up a digital health solution that will support patient self-management and improve the patient-clinician connect. The goal of PAH management is to maintain low-risk […]
STOP (Successful Treatment Of Paranoia) is a patient-facing app that aims to reduce clinical symptoms of paranoia, in patients with mild to moderate paranoia. It is a self-administered 12-week programme using Cognitive Bias Modification for Interpretation therapy (CBM-I). Avegen in collaboration with King’s College London designed and set up STOP, the smartphone version of the therapy.
Klick is a digitally-enabled HIV care pathway conceptualised by Chelsea and Westminster Hospital Foundation Trust (CWFT), Avegen and a major pharmaceutical company. Klick was designed and built by Avegen to integrate with and enhance CWFT’s outpatient service model, whilst delivering a positive experience for patients.